Related Experiment Video
Updated: Aug 28, 2025

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Percutaneous Treatment Approaches in Atrial Fibrillation: Current Landscape and Future Perspectives
Panagiotis Theofilis1, Evangelos Oikonomou2, Alexios S Antonopoulos1
1First Department of Cardiology, "Hippokration" General Hospital, University of Athens Medical School, 11527 Athens, Greece.
Insights
Atrial fibrillation (AF) management now includes catheter ablation for improved outcomes and left atrial appendage occlusion for stroke prevention, offering new options beyond traditional treatments.
Area of Science:
- Cardiology
- Electrophysiology
- Interventional Cardiology
Background:
- Atrial fibrillation (AF) is a prevalent arrhythmia causing significant morbidity and mortality.
- Pharmacologic therapy is standard for rate/rhythm control and thromboembolism prevention.
- Increasing prevalence necessitates advanced therapeutic strategies.
Purpose of the Study:
- To review current and emerging interventional strategies for atrial fibrillation management.
- To evaluate the efficacy of catheter ablation and left atrial appendage occlusion.
Main Methods:
- Review of current literature on catheter ablation techniques for AF.
- Analysis of data on percutaneous left atrial appendage occlusion devices.
- Assessment of outcomes in persistent AF, heart failure, and stroke risk reduction.
Main Results:
- Catheter ablation demonstrates efficacy in achieving long arrhythmia-free intervals and reducing AF burden.
- Left atrial appendage occlusion effectively reduces thromboembolic risk, particularly in high-risk patients.
- Catheter ablation shows promise as a first-line option for persistent AF and heart failure.
Conclusions:
- Percutaneous interventions, including catheter ablation and LAA occlusion, offer valuable alternatives to pharmacologic therapy.
- These approaches significantly improve patient outcomes and reduce complications associated with AF.
- Interventional strategies are crucial for managing AF, especially in specific patient populations.
Abstract:
Atrial fibrillation (AF), the most common sustained arrhythmia in clinical practice, represents a major cause of morbidity and mortality, with an increasing prevalence. Pharmacologic treatment remains the cornerstone of its management through rhythm and rate control, as well as the prevention of thromboembolism with the use of oral anticoagulants. Recent progress in percutaneous interventional approaches have provided additional options in the therapeutic arsenal, however. The use of the different catheter ablation techniques can now lead to long arrhythmia-free intervals and significantly lower AF burden, thus reducing the rate of its complications. Particularly encouraging evidence is now available for patients with persistent AF or concomitant heart failure, situations in which catheter ablation could even be a first-line option. In the field of stroke prevention, targeting the left atrial appendage with percutaneous device implantation may reduce the risk of thromboembolism to lower rates than that predicted with conventional ischemic risk scores. Left atrial appendage occlusion through the approved Watchman or Amplatzer devices is a well-established, efficacious, and safe method, especially in high-ischemic and bleeding risk patients with contraindications for oral anticoagulation.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Peripheral Artery Disease III: Interprofessional Care
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Dysrhythmias VI: Management of Dysrhythmias
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...

